Mechanism-based proteomics tools based on ubiquitin and ubiquitin-like proteins: Crystallography, activity profiling, and protease identification

被引:11
作者
Galardy, P [1 ]
Ploegh, HL
Ovaa, H
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands
来源
UBIQUITIN AND PROTEIN DEGRADATION, PT B | 2005年 / 399卷
关键词
D O I
10.1016/S0076-6879(05)99008-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Isopeptidases that specifically remove ubiquitin or ubiquitin-like molecules from polypeptide adducts are emerging as key regulatory enzymes in a multitude of biochemical pathways. We have developed a set of tools that covalently target the active site of ubiquitin or ubiquitin-like deconjugating enzymes. We have used epitope-tagged ubiquitin and ubiquitin-like derivatives in immunoprecipitation assays to identify active proteases by mass spectrometry (MS/MS). The epitope tag confers the ability to conduct an immunoblot-based profiling assay for active isopeptidases in cell extracts. We have applied a ubiquitin-based probe in the structural analysis of the ubiquitin hydrolase UCH-L3 in its ligand-bound state. We describe the use of these electrophilic derivatives of ubiquitin and ubiquitin-like molecules in the identification, activity profiling, and structural analysis of these proteases. These tools can be used to rapidly profile activity of multiple Ub/UBL-specific proteases in parallel in cell extracts. We also show that in vitro these probes can be conjugated onto parts of the Ub/UBL conjugating machinery.
引用
收藏
页码:120 / +
页数:13
相关论文
共 29 条
  • [1] Identification of the familial cylindromatosis tumour-suppressor gene
    Bignell, GR
    Warren, W
    Seal, S
    Takahashi, M
    Rapley, E
    Barfoot, R
    Green, H
    Brown, C
    Biggs, PJ
    Lakhani, SR
    Jones, C
    Hansen, J
    Blair, E
    Hofmann, B
    Siebert, R
    Turner, G
    Evans, DG
    Schrander-Stumpel, C
    Beemer, FA
    van den Ouweland, A
    Halley, D
    Delpech, B
    Cleveland, MG
    Leigh, I
    Leisti, J
    Rasmussen, S
    Wallace, MR
    Fenske, C
    Banerjee, P
    Oiso, N
    Chaggar, R
    Merrett, S
    Leonard, N
    Huber, M
    Hohl, D
    Chapman, P
    Burn, J
    Swift, S
    Smith, A
    Ashworth, A
    Stratton, MR
    [J]. NATURE GENETICS, 2000, 25 (02) : 160 - 165
  • [2] Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme
    Borodovsky, A
    Ovaa, H
    Kolli, N
    Gan-Erdene, T
    Wilkinson, KD
    Ploegh, HL
    Kessler, BM
    [J]. CHEMISTRY & BIOLOGY, 2002, 9 (10): : 1149 - 1159
  • [3] A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14
    Borodovsky, A
    Kessler, BM
    Casagrande, R
    Overkleeft, HS
    Wilkinson, KD
    Ploegh, HL
    [J]. EMBO JOURNAL, 2001, 20 (18) : 5187 - 5196
  • [4] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [5] Ribbons
    Carson, M
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 : 493 - 505
  • [6] Rapid Ca2+-dependent decrease of protein ubiquitination at synapses
    Chen, H
    Polo, S
    Di Fiore, PP
    De Camilli, PV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) : 14908 - 14913
  • [7] Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23
    Cohen, M
    Stutz, F
    Belgareh, N
    Haguenauer-Tsapis, R
    Dargemont, C
    [J]. NATURE CELL BIOLOGY, 2003, 5 (07) : 661 - U47
  • [8] The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
    Glickman, MH
    Ciechanover, A
    [J]. PHYSIOLOGICAL REVIEWS, 2002, 82 (02) : 373 - 428
  • [9] The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
    Graner, E
    Tang, D
    Rossi, S
    Baron, A
    Migita, T
    Weinstein, LJ
    Lechpammer, M
    Huesken, D
    Zimmermann, J
    Signoretti, S
    Loda, M
    [J]. CANCER CELL, 2004, 5 (03) : 253 - 261
  • [10] GRAY DA, 1995, ONCOGENE, V10, P2179